May 27, 2010 - 6:53 pm
I had a radical nephrectomy March 25, 2010, with great recovery , completely confined to kidney. Pathology showed chromophobe subtype of RCC which is less aggressive form. Only negative was size of tumor, 14cm. I was told my likelihood not having a recurrence in 5 years is 83%. My oncologist suggested ASSURE trial. I am STRUGGLING with this decision as I am young (45), active, healthy, and single mom to 2 kids, and I work. Anyone who has experience with either drug, Sutent or Sorafenib, or with the trial, I would really appreciate your input! I'm a basket case wondering what the right choice is! Thank you!